Journal of Virological Methods 1991: Vol 33 Index

7 Pages·1991·0.99 MB·English

Author Index
Aboagye-Mathiesen, G., see Zachar, V., 391 situ hybridization, 253
Adam, K.-H., see Marquardt, O., 267 Collie, M.J., see Lee, Y.S., 217
Agbede, O., Wahab, S., Schutt, D.L. and Lucia, Cooper, S., see Battegay, M., 191
H.L., Performance characteristics of a rapid Cornelis, J.J., see Rommelaere, J., 233
Western blot assay system for antibody human
immunodeficiency virus type 1, 291 Dunez, J., see Wetzel, T., 355
Ait-Khaled, M., see Fox, J.C., 375
Althage, A., see Battegay, M., 191 Ebbesen, P., see Zachar, V., 391
Aramburu, J., Navas-Castillo, J., Moreno, P. and Efandis, T., see Nicholson, S., 311
Cambra, M., Detection of double-stranded RNA Emery, V.C., see Fox, J.C., 375
by ELISA and dot immunobinding assay using Evans, D.H., see Zhang, W., 165
an antiserum to synthetic polynucleotides, |
Ayisi, N.K., Gupta, S.V. and Qualtiere, L.F., Fairley, C.K., see Nicholson, S., 311
Modified tetrazolium-based colorimetric meth- Farrah, S.R., see Preston, D.R., 383
od for determining the activities of anti-HIV Fitzgerald, T.A. and Browning, G.F., Increased
compounds, 335 sensitivity of a rotavirus serotyping enzyme-
Aymard, M., see Njayou, M., 53 linked immunosorbent assay by the incorpora-
tion of CaCl), 299
Baba, M., see Takeuchi, H., 61 Fong, C.K.Y. and Landry, M.L., Advantages of
Battegay, M., Cooper, S., Althage, A., Banziger, J., multiple cell culture systems for detection of
Hengartner, H. and Zinkernagel, R.M., Quanti- mixed-virus infections, 283
fication of lymphocytic choriomeningitis virus Fox, J.C., Ait-Khaled, M., Webster, A. and Emery,
with an immunological focus assay in 24- or 96- V.C., Eliminating PCR contamination: is UV
well plates, 191 irradiation the answer?, 375
Beatrice, S.T., see Lee, Y.S., 217 Francki, R.I.B., see Hajimorad, M.R., 13
Besselaar, T.G., see Blackburn, N.K., 367 Friedman-Kien, A.E., see McClintock, J.T., 155
Biehler, K., see Spada, B., 305
Binninger, I., see Clavel, C., 253 Garnett, H., see Steiner, K.A., 199
Birembaut, P., see Clavel, C., 253 Glaser, R., see Tsai, C.-H.A., 47
Bitton, G., see Preston, D.R., 383 Gubler, D.J., see Kuno, G., 101
Blackburn, N.K. and Besselaar, T.G., A study of Gulakowski, R.J., McMahon, J.B., Staley, P.G.,
the effect of chemical inactivants on the epitopes Moran, R.A. and Boyd, M.R., A semiautomated
of Rift Valley fever virus glycoproteins using multiparameter approach for anti-HIV drug
monoclonal antibodies, 367 screening, 87
Boutterin, M.-C., see Clavel, C., 253 Gupta, S.V., see Ayisi, N.K., 335
Boyd, M.R., see Gulakowski, R.J., 87 Gust, I.D., see Nicholson, S., 311
Browning, G.F., see Fitzgerald, T.A., 299 Gomez, I., see Kuno, G., 101
Banziger, J., see Battegay, M., 191
Haggard, D.L., see Murtaugh, M.P., 73
Cambra, M., see Aramburu, J., 1 Hajdu, L., see Klintevall, K., 319
Candresse, T., see Wetzel, T., 355 Hajimorad, M.R. and Francki, R.I.B., Effect of
Chan, I.-J., see McClintock, J.T., 155 glutaraldehyde-fixation on the immunogenicity,
Chang, P.W., see Sadasiv, E.C., 115 particle stability and antigenic reactivity of
Chaudhhry, G.R., see Preston, D.R., 383 alfalfa mosaic virus, and the specificity of
Chegas, P., see Spada, B., 305 elicited antibodies, 13
Clavel, C., Binninger, I., Boutterin, M.-C., Polette, Harding, R.M., see Karan, M., 211
M. and Birembaut, P., Comparison of four non- Hengartner, H., see Battegay, M., 191
radioactive and *°S-based methods for the Hicks, S., see Karan, M., 211
detection of human papillomavirus DNA by in Hirano, A. and Wong, T.C., Generation of
400
mammalian cells expressing stably measles virus proteins of bovine leukemia virus (gp51 and p24)
proteins via bicistronic RNA, 135 and their use for discrimination between vacci-
Hornitzky, C., see Steiner, K.A., 199 nated and infected animals, 345
Moran, R.A., see Gulakowski, R.J., 87
Karan, M., Hicks, S., Harding, R.M. and Teakle, Morein, B., see Merza, M., 345
D.S., Stability and extractability of double- Morello, J.A., see Smaron, M.F., 223
stranded RNA of pangola stunt and sugarcane Moreno, P., see Aramburu, J., 1
Fiji disease viruses in dried plant tissues, 211 Murtaugh, M.P., Lin, G.F., Haggard, D.L.,
Kaye, J., see Spada, B., 305 Weber, A.F. and Meiske, J.C., Detection of
Klingeborn, B., see Klintevall, K., 319 bovine leukemia virus in cattle by the polymerase
Klintevall, K., Naslund, K., Svedlund, G., Hajdu, chain reaction, 73
L., Linde, N. and Klingeborn, B., Evaluation of
an indirect ELISA for the detection of antibodies Navas-Castillo, J., see Aramburu, J., 1
to bovine leukaemia virus in milk and serum, 319 Nicholson, S., Leslie, D.E., Efandis, T., Fairley,
Knowlton, D.R., Spector, D.M. and Ward, R.L., C.K. and Gust, I.D., Hepatitis C antibody
Development of an improved method for testing: problems associated with non-specific
measuring neutralizing antibody to rotavirus, binding, 311
127 Njayou, M., Aymard, M. and Quash, G., Epide-
Krueger, L.E., see Swenson, P.D., 27 miology of measles in the Cameroons between
Kuno, G., Gomez, I. and Gubler, D.J., An ELISA 1984 and 1986: comparison of the effectiveness
procedure for the diagnosis of dengue infections, of different serological methods in rural regions,
101 53
Norskov-Lauritsen, N., see Zachar, V., 391
Lamy, D., A microcomputer program simulating Naslund, K., see Klintevall, K., 319
rate zonal centrifugation, 149
Landry, M.L., see Fong, C.K.Y., 283 Petersen, R.K., see Steiner, K.A., 199
Lee, Y.S., Collie, M.J., Leung, L.K.H., Seidlin, M. Polette, M., see Clavel, C., 253
and Beatrice, $.T., Comparison of Immobilon-N Preston, D.R., Farrah, S.R., Bitton, G. and
membrane and other membranes for the detec- Chaudhhry, G.R., Detection of nucleic acids
tion of HIV-1 genome in high risk patients using homologous to human immunodeficiency virus
PCR, 217 in wastewater, 383
Leslie, D.E., see Nicholson, S., 311
Leung, L.K.H., see Lee, Y.S., 217 Qualtiere, L.F., see Ayisi, N.K., 335
Levy, J.A., see Tang, S., 39 Quash, G., see Njayou, M., 53
Lin, G.F., see Murtaugh, M.P., 73
Linde, N., see Klintevall, K., 319 Ravelonandro, M., see Wetzel, T., 355
Lucia, H.L., see Agbede, O., 291 Resnick, L., see McClintock, J.T., 155
Riepenhoff-Talty, M., see Spada, B., 305
Marquardt, O., Adam, K.-H. and Straub, O.C., Riess, J.T., see Swenson, P.D., 27
Detection and localization of single-base se- Rommelaere, J. and Cornelis, J.J., Antineoplastic
quence differences in foot-and-mouth disease activity of parvoviruses, 233
virus genomes by the RNase mismatch cleavage
method, 267 Sadasiv, E.C., Yeh, T.T. and Chang, P.W., Protein
Mayer, V., see Zachar, V., 391 pI alteration related to strain variation of
McCarthy, C., see Smaron, M.F., 223 infectious bronchitis virus, an avian Corona-
McClintock, J.T., Chan, I.-J., Taub, F.E., Fried- virus, 115
man-Kien, A.E. and Resnick, L., Rapid detec- Saxon, E., see Smaron, M.F., 223
tion of Epstein-Barr virus DNA in clinical Schutt, D.L., see Agbede, O., 291
samples of oral hairy leukoplakia with HRP- Seidlin, M., see Lee, Y.S., 217
labeled DNA probes and in situ hybridization, Shigeta, S., see Takeuchi, H., 61
155 Smaron, M.F., Saxon, E., Wood, L., McCarthy, C.
McMahon, J.B., see Gulakowski, R.J., 87 and Morello, J.A., Diagnosis of measles by
Meiske, J.C., see Murtaugh, M.P., 73 fluorescent antibody and culture of nasophar-
Merza, M., Sundquist, B., Séber, J. and Morein, yngeal secretions, 223
B., Immunoaffinity purification of two major Spada, B., Biehler, K., Chegas, P., Kaye, J. and
401
Riepenhoff-Talty, M., Comparison of rapid Characterization of two monoclonal antibodies
immunofluorescence assay to cell culture isola- to Epstein-Barr virus diffuse early antigen which
tion for the detection of influenza A and B react to two different epitopes and have different
viruses in nasopharyngeal secretions from in- biological function, 47
fants and children, 305
Spector, D.M., see Knowlton, D.R., 127 Wahab, S., see Agbede, O., 291
Staley, P.G., see Gulakowski, R.J., 87 Ward, R.L., see Knowlton, D.R., 127
Steiner, K.A., Whittington, R.J., Petersen, R.K.., Weber, A.F., see Murtaugh, M.P., 73
Hornitzky, C. and Garnett, H., Purification of Webster, A., see Fox, J.C., 375
epizootic haematopoietic necrosis virus and its Wetzel, T., Candresse, T., Ravelonandro, M. and
detection using ELISA, 199 Dunez, J., A polymerase chain reaction assay
Straub, O.C., see Marquardt, O., 267 adapted to plum pox potyvirus detection, 355
Sundquist, B., see Merza, M., 345 Whittington, R.J., see Steiner, K.A., 199
Svedlund, G., see Klintevall, K., 319 Williams, M.V., see Tsai, C.-H.A., 47
Swenson, P.D., Riess, J.T. and Krueger, L.E., Wong, T.C., see Hirano, A., 135
Determination of HBsAg subtypes in different Wood, L., see Smaron, M.F., 223
high risk populations using monoclonal anti-
bodies, 27 Yeh, T.T., see Sadasiv, E.C., 115
Sober, J., see Merza, M., 345
Zachar, V., Mayer, V., Aboagye-Mathiesen, G.,
Takeuchi, H., Baba, M. and Shigeta, S., An Norskov-Lauritsen, N. and Ebbesen, P., En-
application of tetrazolium (MTT) colorimetric hanced chemiluminescence-based hybridization
assay for the screening of anti-herpes simplex analysis for PCR-mediated HIV-1 DNA detec-
virus compounds, 61 tion offers an alternative to >*P-labelled probes,
Tang, S. and Levy, J.A., Inactivation of HIV-1 by 391
trypsin and its use in demonstrating specific virus Zhang, W. and Evans, D.H., Detection and
infection of cells, 39 identification of human influenza viruses by the
Taub, F.E., see McClintock, J.T., 155 polymerase chain reaction, 165
Teakle, D.S., see Karan, M., 211 Zinkernagel, R.M., see Battegay, M., 191
Tsai, C.-H.A., Williams, M.V. and Glaser, R.,

Subject Index
Alfalfa mosaic virus, Polyclonal antibody, Glutar- DNA probe, In situ hybridization, Epstein-Barr
aldehyde-fixation, Immunogenicity, Antigenic virus, Viral DNA detection, Horseradish per-
reactivity, 13 oxidase labeling, 155
Anti-HIV assay, Fluorescence, Drug screening, 87 Dengue, Laboratory diagnosis, ELISA, 101
Antibody, Predictive value, Non-specificity, 312 Detection System, Multiple-viruses, Cell culture,
Antigen-capture ELISA, Epizootic haematopoietic 283
necrosis virus, Viral purification, Rainbow Digoxigenin-labelled DNA probe, Human papillo-
trout, Redfin perch, 199 mavirus, In situ hybridization, Non-radioactive
Antigenic reactivity, Alfalfa mosaic virus, Polyclo- DNA probe, Sulphonated DNA probe, Bioti-
nal antibody, Glutaraldehyde-fixation, Immu- nylated DNA probe, 253
nogenicity, 13 Dihydrofolate reductase, Stable expression, Measles
Antiviral assay, Herpes simplex virus, B-lympho- virus protein, Bicistronic RNA, 135
blastoid cell, MTT, 61 Dot immunobinding assay, Double-stranded RNA,
ELISA, Serological detection, 1
B-lymphoblastoid cell, Herpes simplex virus, Anti- Dot-blot hybridization, HIV-1, PCR, PVDF mem-
viral assay, MTT, 61 brane, 217
Bicistronic RNA, Stable expression, Measles virus Double-stranded RNA, Dot immunobinding assay,
protein, Dihydrofolate reductase, 135 ELISA, Serological detection, 1
Biophysical parameter, Coronavirus classification, Double-stranded RNA, Plant reovirus, Dried leaf,
Isoelectric focusing, Strain variation, 115 211
Biotinylated DNA probe, Human papillomavirus, Dried leaf, Double-stranded RNA, Plant reovirus,
In situ hybridization, Non-radioactive DNA 211
probe, Sulphonated DNA probe, Digoxigenin- Drug screening, Anti-HIV assay, Fluorescence, 87
labelled DNA probe, 253
Bovine leukemia virus, BLV, Polymerase chain EBV, Early antigen, Monoclonal antibody, 47
reaction, PCR, 73 ELISA, Bovine leukemia virus, BLV, Envelope
Bovine leukaemia virus, Indirect ELISA, Serum, glycoprotein gp51, Core protein p24, 345
Milk, Herd screening, Eradication programme, ELISA, Dengue, Laboratory diagnosis, 101
Sweden, 319 ELISA, Double-stranded RNA, Dot immunobind-
Bovine leukemia virus, BLV, ELISA, Envelope ing assay, Serological detection, 1
glycoprotein gp51, Core protein p24, 345 ELISA, Rotavirus, Neutralizing antibody titer, 127
ELISA, Rotavirus serotyping, G serotype, 299
CD4 receptor, HIV, Virus inactivation, Trypsin, Early antigen, EBV, Monoclonal antibody, 47
Surface binding, 39 Envelope glycoprotein gp51, ELISA, Bovine leuke-
Cell culture, Multiple-viruses, Detection System, mia virus, BLV, Core protein p24, 345
283 Epizootic haematopoietic necrosis virus, Viral pur-
Cell culture isolation, CCI, Immunofluorescence ification, Antigen-capture ELISA, Rainbow
assay, IFA, 305 trout, Redfin perch, 199
Chemiluminescence, PCR, Nonisotopic hybridiza- Epstein-Barr virus, In situ hybridization, Viral
tion, HIV, 391 DNA detection, Horseradish peroxidase label-
Chemotherapy, HIV, MTT, PPL, Modified formu- ing, DNA probe, 155
la, 335 Eradication programme, Bovine leukaemia virus,
Core protein p24, ELISA, Bovine leukemia virus, Indirect ELISA, Serum, Milk, Herd screening,
BLV, Envelope glycoprotein gp51, 345 Sweden, 319
Coronavirus classification, Isoelectric focusing,
Strain variation, Biophysical parameter, 115 Fluorescence, Anti-HIV assay, Drug screening, 87
Cytomegalovirus, PCR, UV light, Human immu- Focus formation, Lymphocytic choriomeningitis
nodeficiency virus, 375 virus, Virus titration, Multi-well plate, 191
404
Foot-and-mouth disease virus, RNA double-strands, glutination inhibition (HAI) ELISA, Indirect
RNase A, RNase T1, 267 immunoperoxidase (IIP), 53
Indirect immunoperoxidase (IIP), Measles hemag-
G serotype, Rotavirus serotyping, ELISA, 299 glutination inhibition (HAI) ELISA, Indirect
Glutaraldehyde-fixation, Alfalfa mosaic virus, Poly- immunofluorescence (IIF), 53
clonal antibody, Immunogenicity, Antigenic Influenza, PCR, Viral cDNA preparation, Subtyp-
reactivity, 13 ing, 166
Glycoprotein, Rift Valley fever virus, Monoclonal Isoelectric focusing, Coronavirus classification,
antibody, Inactivant, 367 Strain variation, Biophysical parameter, 115
HIV, Chemiluminescence, PCR, Nonisotopic hy- Laboratory diagnosis, Dengue, ELISA, 101
bridization, 391 Lymphocytic choriomeningitis virus, Focus forma-
HIV, Chemotherapy, MTT, PPL, Modified for- tion, Virus titration, Multi-well plate, 191
mula, 335
HIV, Virus inactivation, Trypsin, CD4 receptor, MTT, HIV, Chemotherapy, PPL, Modified for-
Surface binding, 39 mula, 335
HIV-1, PCR, Dot-blot hybridization, PVDF MTT, Herpes simplex virus, B-lymphoblastoid cell,
membrane, 217 Antiviral assay, 61
Hepatitis B virus, Hepatitis B surface antigen Measles culture, Measles immunofluorescence,
subtype, Monoclonal antibody, 27 Measles monoclonal antibody, 223
Hepatitis B surface antigen subtype, Hepatitis B Measles hemagglutination inhibition (HAI) ELISA,
virus, Monoclonal antibody, 27 Indirect immunofluorescence (IIF), Indirect
Herd screening, Bovine leukaemia virus, Indirect immunoperoxidase (IIP), 53
ELISA, Serum, Milk, Eradication programme, Measles i escence, Measles monoclonal
Sweden, 319 antibody, Measles culture, 223
Herpes simplex virus, B-lymphoblastoid cell, Anti- Measles monoclonal antibody, Measles immuno-
viral assay, MTT, 61 fluorescence, Measles culture, 223
Horseradish peroxidase labeling, In situ hybridiza- Measles virus protein, Stable expression, Dihydro-
tion, Epstein-Barr virus, Viral DNA detection, folate reductase, Bicistronic RNA, 135
DNA probe, 155 Milk, Bovine leukaemia virus, Indirect ELISA,
Human immunodeficiency virus, PCR, UV light, Serum, Herd screening, Eradication pro-
Cytomegalovirus, 375 gramme, Sweden, 319
Human papillomavirus, In situ hybridization, Non- Modified formula, HIV, Chemotherapy, MTT,
radioactive DNA probe, Sulphonated DNA PPL, 335
probe, Biotinylated DNA probe, Digoxigenin- Monoclonal antibody, Hepatitis B virus, Hepatitis B
labelled DNA probe, 253 surface antigen subtype, 27
Monoclonal antibody, EBV, Early antigen, 47
escence assay, IFA, Cell culture isola- Monoclonal antibody, Rift Valley fever virus,
tion, CCI, 305 Glycoprotein, Inactivant, 367
Immunogenicity, Alfalfa mosaic virus, Polyclonal Multi-well plate, Lymphocytic choriomeningitis
antibody, Glutaraldehyde-fixation, Antigenic virus, Focus formation, Virus titration, 191
reactivity, 13 Multiple-viruses, Cell culture, Detection System,
In situ hybridization, Epstein-Barr virus, Viral 283
DNA detection, Horseradish peroxidase label-
ing, DNA probe, 155 Neoplastic transformation, Parvovirus, Tumor
In situ hybridization, Human papillomavirus, Non- suppression, 234
radioactive DNA probe, Sulphonated DNA Neutralizing antibody titer, Rotavirus, ELISA, 127
probe, Biotinylated DNA probe, Digoxigenin- Non-radioactive DNA probe, Human papilloma-
labelled DNA probe, 253 virus, In situ hybridization, Sulphonated DNA
Inactivant, Rift Valley fever virus, Glycoprotein, probe, Biotinylated DNA probe, Digoxigenin-
Monoclonal antibody, 367 labelled DNA probe, 253
Indirect ELISA, Bovine leukaemia virus, Serum, Non-specificity, Antibody, Predictive value, 312
Milk, Herd screening, Eradication programme, Nonisotopic hybridization, Chemiluminescence,
Sweden, 319 PCR, HIV, 391
Indirect i fl escence (IIF), Measles hemag-
405
PCR, Chemiluminescence, Nonisotopic hybridiza- Serological detection, Double-stranded RNA, Dot
tion, HIV, 391 immunobinding assay, ELISA, 1
PCR, HIV-1, Dot-blot hybridization, PVDF Serum, Bovine leukaemia virus, Indirect ELISA,
membrane, 217 Milk, Herd screening, Eradication programme,
PCR, Influenza, Viral cDNA preparation, Subtyp- Sweden, 319
ing, 166 Stable expression, Measles virus protein, Dihydro-
PCR, UV light, Cytomegalovirus, Human immu- folate reductase, Bicistronic RNA, 135
nodeficiency virus, 375 Strain variation, Coronavirus classification, Iso-
PPL, HIV, Chemotherapy, MTT, Modified for- electric focusing, Biophysical parameter, 115
mula, 335 Subtyping, PCR, Influenza, Viral cDNA prepara-
PVDF membrane, HIV-1, PCR, Dot-blot hybridi- tion, 166
zation, 217 Sucrose gradient, Zone centrifugation, Sedimenta-
Parvovirus, Tumor suppression, Neoplastic trans- tion coefficient, 149
formation, 234 Sulphonated DNA probe, Human papillomavirus,
Plant reovirus, Double-stranded RNA, Dried leaf, In situ hybridization, Non-radioactive DNA
211 probe, Biotinylated DNA probe, Digoxigenin-
Plum pox potyvirus, PPV, Polymerase chain labelled DNA probe, 253
reaction, PCR, Polymorphism, 355 Surface binding, HIV, Virus inactivation, Trypsin,
Polyclonal antibody, Alfalfa mosaic virus, Glutar- CD4 receptor, 39
aldehyde-fixation, Immunogenicity, Antigenic Sweden, Bovine leukaemia virus, Indirect ELISA,
reactivity, 13 Serum, Milk, Herd screening, Eradication
Polymerase chain reaction, PCR, Bovine leukemia programme, 319
virus, BLV, 73
Polymerase chain reaction, PCR, Plum pox poty- Trypsin, HIV, Virus inactivation, CD4 receptor,
virus, PPV, Polymorphism, 355 Surface binding, 39
Polymorphism, Polymerase chain reaction, PCR, Tumor suppression, Parvovirus, Neoplastic trans-
Plum pox potyvirus, PPV, 355 formation, 234
Predictive value, Antibody, Non-specificity, 312
UV light, PCR, Cytomegalovirus, Human immu-
RNA double-strands, Foot-and-mouth disease nodeficiency virus, 375
virus, RNase A, RNase T1, 267
RNase A, Foot-and-mouth disease virus, RNA Viral DNA detection, In situ hybridization, Epstein-
double-strands, RNase T1, 267 Barr virus, Horseradish peroxidase labeling,
RNase T1, Foot-and-mouth disease virus, RNA DNA probe, 155
double-strands, RNase A, 267 Viral cDNA preparation, PCR, Influenza, Subtyp-
Rainbow trout, Epizootic haematopoietic necrosis ing, 166
virus, Viral purification, Antigen-capture ELI- Viral purification, Epizootic haematopoietic necro-
SA, Redfin perch, 199 sis virus, Antigen-capture ELISA, Rainbow
Redfin perch, Epizootic haematopoietic necrosis trout, Redfin perch, 199
virus, Viral purification, Antigen-capture ELI- Virus inactivation, HIV, Trypsin, CD4 receptor,
SA, Rainbow trout, 199 Surface binding, 39
Rift Valley fever virus, Glycoprotein, Monoclonal Virus titration, Lymphocytic choriomeningitis
antibody, Inactivant, 367 virus, Focus formation, Multi-well plate, 191
Rotavirus serotyping, ELISA, G serotype, 299
Rotavirus, Neutralizing antibody titer, ELISA, 127 Zone centrifugation, Sucrose gradient, Sedimenta-
tion coefficient, 149
Sedimentation coefficient, Zone centrifugation,
Sucrose gradient, 149